Health Center

1. S*Bio Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial...
1 /PRNewswire/ -- S*BIO Pte Ltd today announced the initiation of a Phase 1/2 clinical trial of SB1518, a potent and orally-active JAK2 inhibitor, in leading medical centers in Australia for patients with chronic idiopathic ...

2. S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial...
S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis.

3. DJ HUGIN NEWS/Micromet Expands Committed Equity Financing Facility ...
clinical trial for the treatment of patients with non-Hodgkin's lymphoma. Micromet is developing blinatumomab in collaboration with MedImmune, a subsidiary of AstraZeneca plc. Micromet's second BiTE antibody in clinical development is ...

4. financial.de » DJ HUGIN NEWS/Micromet Expands Committed Equity -2-
It is in a phase 2 clinical trial for the treatment of patients with acute lymphoblastic leukemia and a phase 1 clinical trial for the treatment of patients with non-Hodgkin's lymphoma. Micromet is developing blinatumomab in ...

5. financial.de » DJ HUGIN NEWS/Micromet Expands Committed Equity ...
Micromet is developing blinatumomab in collaboration with MedImmune, a subsidiary of AstraZeneca plc. Micromet's second BiTE antibody in clinical development is MT110, which targets the epithelial cell adhesion molecule (EpCAM). ...

6. Asia Healthcare News » GCC countries need to give greater ...
JUPITER is a part of AstraZeneca’s extensive GALAXY clinical trials program, designed to address important unanswered questions in statin research. Currently, more than 69000 patients have been recruited from 55 countries worldwide to ...

7. Overseas Drug Trials Come Under Scrutiny // Pharmalot
India has approved some 450 clinical trials this year, up from about 100 in 2005. Wyeth says about 45 percent of its mid- and late-stage trial participants come from outside the U.S. and Western Europe. Trials in lower-income countries ...

8. Job Detail | Clinical Research Manager | PharmiWeb.com
Pharmaceutical job vacancy : Clinical Research Manager |

9. Generics Are As Good Brand-Name Meds: Study // Pharmalot
Of the 47 articles, 38 (or 81 percent) were randomized controlled trials, according to a JAMA statement. Here’s what they found… Clinical equivalence was noted in 100 percent of RCTs of beta-blockers; 91 percent of RCTs of diuretics; ...

10. ALLIANCE FOR HUMAN RESEARCH PROTECTION: Pharma Marketing Tactics ...
Financially compromised psychiatrists regularly pen their name (for hefty fees) to industry-generated clinical trial reports and clinical practice guidelines whose prescription drug recommendations have propelled the most toxic ...